# A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy

> **NCT05549791** · — · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 1285 (actual)

## Conditions studied

- General Anesthesia and Bronchoscopy Sedation

## Interventions

- **DRUG:** Remimazolam Tosilate for Injection

## Key facts

- **NCT ID:** NCT05549791
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-18
- **Primary completion:** 2024-06-21
- **Final completion:** 2024-06-21
- **Target enrollment:** 1285 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05549791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05549791, "A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05549791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*